Class II

Drug Recall: Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.

Preferred Pharmaceuticals, Inc. · April 18, 2025

Reason for Recall

cGMP Deviations

Distribution

Nationwide in the US

States Affected

NATIONWIDE

Quantity Affected

1190 Bottles

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0391-2025

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.